The legal barrage comes months after the FDA in December 2024 affirmed that tirzepatide is no longer in shortage and formally barred compounders, who had legally been allowed to make the drug while it was in shortage, from producing and distributing knockoff versions, giving them until March 19 to comply
Cell Stem Cell 5 : 504514
Wir, Tania Tschirner, Carmen Teller, Greta Schulz und Evelyn Methe begren Sie auf unserer Homepage
Xiao Z, Cilz NI, Kurada L et al (2014) Activation of neurotensin receptor 1 facilitates neuronal excitability and spatial learning and memory in the entorhinal cortex: beneficial actions in an Alzheimers disease model
Alhowail, [email protected] Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers